PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30639312-9	2019	Mechanistically, saxagliptin exerted inhibitory effects against ox-LDL-induced phosphorylation of JNK kinase, expression of the activator protein 1 (AP-1) subunits c-Jun/c-fos, and AP-1 promoter activity.	saxagliptin	17-28	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	128-147	
30639312-0	2019	The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-kappaB.	saxagliptin	20-31	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	97-101	
30639312-9	2019	Mechanistically, saxagliptin exerted inhibitory effects against ox-LDL-induced phosphorylation of JNK kinase, expression of the activator protein 1 (AP-1) subunits c-Jun/c-fos, and AP-1 promoter activity.	saxagliptin	17-28	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	149-153	
30639312-9	2019	Mechanistically, saxagliptin exerted inhibitory effects against ox-LDL-induced phosphorylation of JNK kinase, expression of the activator protein 1 (AP-1) subunits c-Jun/c-fos, and AP-1 promoter activity.	saxagliptin	17-28	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	164-169	
30639312-9	2019	Mechanistically, saxagliptin exerted inhibitory effects against ox-LDL-induced phosphorylation of JNK kinase, expression of the activator protein 1 (AP-1) subunits c-Jun/c-fos, and AP-1 promoter activity.	saxagliptin	17-28	Jun proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	181-185